>
✏️ Posts:
17,411
1. |
COVID19 |
Deaths during Corona pandemic largely among overweight people (dutch)
2023-09-29 06:41:51 EST
Source
|
|
2. |
COVID19 |
New-Onset Arthritis Following COVID-19 Vaccination: A Systematic Review of Case Reports
2023-09-29 06:17:18 EST
Source
|
|
3. |
COVID19 |
DNA in mRNA vaccines
2023-09-28 02:10:55 EST
Source
|
|
4. |
COVID19 |
Duration of SARS-CoV-2 mRNA vaccine persistence and factors associated with cardiac involvement in recently vaccinated patients
2023-09-27 19:15:11 EST
Source
|
|
5. |
COVID19 |
A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes
2023-09-25 17:57:42 EST
Source
|
|
6. |
COVID19 |
Distinguishing features of Long COVID identified through immune profiling
2023-09-25 13:21:06 EST
Source
|
|
7. |
COVID19 |
Bone marrow alterations in COVID-19 infection: The root of hematological problems
2023-09-23 20:04:29 EST
Source
|
|
8. |
COVID19 |
How do they know "no reason you can't" if no research: "there have not yet been formal studies into co-administering the RSV vaccine with either the flu or COVID vaccines. That said, there should be no reason why you can’t get the RSV vaccine at the same time as the COVID vaccine."
2023-09-23 14:16:52 EST
Source
|
|
9. |
COVID19 |
Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study
2023-09-22 20:39:35 EST
Source
|
|
10. |
COVID19 |
Severe acute respiratory syndrome coronavirus 2 infection leads to Tau pathological signature in neurons
2023-09-22 19:34:47 EST
Source
|
|
11. |
COVID19 |
Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection
2023-09-22 13:39:33 EST
Source
|
|
12. |
COVID19 |
Covid 'stay at home' warning issued after new strain detected in Britain
2023-09-22 11:06:11 EST
Source
|
|
13. |
COVID19 |
SARS-CoV-2 variants evolve convergent strategies to remodel the host response
2023-09-21 14:55:28 EST
Source
|
|
14. |
COVID19 |
Ongoing symptoms and functional impairment 12 weeks after testing positive for SARS-CoV-2 or influenza in Australia: an observational cohort study
2023-09-21 05:23:16 EST
Source
|
|
15. |
COVID19 |
“Postvaccination myocarditis has been found to be equivalent to or exceed the risk of post-COVID myocarditis in males less than 40 years old…”
2023-09-20 12:34:47 EST
Source
|
|
16. |
COVID19 |
Association between virus variants, vaccination, previous infections, and post-COVID-19 risk
2023-09-20 12:04:25 EST
Source
|
|
17. |
COVID19 |
Multisystem Inflammatory Syndrome in Children Among Persons Who Completed a Two-dose COVID-19 Vaccine Primary Series Compared With Those Reporting No COVID-19 Vaccination, US National MIS-C Surveillance
2023-09-20 04:55:33 EST
Source
|
|
18. |
COVID19 |
Patient-reported reactogenicity and safety of COVID-19 vaccinations vs. comparator vaccinations: a comparative observational cohort study
2023-09-20 04:43:03 EST
Source
|
|
19. |
COVID19 |
Biodistribution of mRNA COVID-19 vaccines in human breast milk
2023-09-19 20:56:25 EST
Source
|
|
20. |
COVID19 |
A highly divergent SARS-CoV-2 lineage B.1.1 sample in a patient with long-term COVID-19
2023-09-19 15:41:01 EST
Source
|
|
21. |
COVID19 |
Brain Pathology in COVID-19: Clinical Manifestations and Potential Mechanisms
2023-09-18 22:59:23 EST
Source
|
|
22. |
COVID19 |
Comparative study showed that children faced a 78% higher risk of new-onset conditions after they had COVID-19
2023-09-18 17:19:25 EST
Source
|
|
23. |
COVID19 |
Omega-3 polyunsaturated fatty acids and the psychiatric post-acute sequelae of COVID-19: A one-year retrospective cohort analysis of 33,908 patients
2023-09-18 02:17:08 EST
Source
|
|
24. |
COVID19 |
Genetic tracing of market wildlife and viruses at the epicenter of the COVID-19 pandemic
2023-09-17 20:20:53 EST
Source
|
|
25. |
COVID19 |
Concurrent administration of COVID-19 and influenza vaccines enhances Spike-specific antibody responses
2023-09-17 14:07:20 EST
Source
|
|
26. |
COVID19 |
SARS-CoV-2 sublingual vaccine with RBD antigen and poly(I:C) adjuvant: Preclinical study in cynomolgus macaques | Biology Methods and Protocols
2023-09-16 19:32:10 EST
Source
|
|
27. |
COVID19 |
Proximal immune-epithelial progenitor interactions drive chronic tissue sequelae post COVID-19
2023-09-16 13:06:06 EST
Source
|
|
28. |
COVID19 |
Receipt of BNT162b2 Vaccine and COVID-19 Ambulatory Visits in US Children Younger Than 5 Years
2023-09-16 10:37:16 EST
Source
|
|
29. |
COVID19 |
Receipt of BNT162b2 Vaccine and COVID-19 Ambulatory Visits in Young US Children
2023-09-16 09:23:29 EST
Source
|
|
30. |
COVID19 |
Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial
2023-09-15 13:19:24 EST
Source
|
|
31. |
COVID19 |
Immune Evasion, Infectivity, and Fusogenicity of SARS-CoV-2 Omicron BA.2.86 and FLip Variants
2023-09-14 14:14:45 EST
Source
|
|
32. |
COVID19 |
new covid shots in us.
2023-09-13 16:27:24 EST
Source
|
|
33. |
COVID19 |
The gray swan: model-based assessment of the risk of sudden failure of hybrid immunity to SARS-CoV-2
2023-09-13 16:04:46 EST
Source
|
|
34. |
COVID19 |
Whistleblower alleges CIA bribery in COVID-19 origin probe; agency denies
2023-09-13 10:23:59 EST
Source
|
|
35. |
COVID19 |
Digital holo-tomographic 3D maps of COVID-19 microclots in blood to assess disease severity
2023-09-13 03:44:17 EST
Source
|
|
36. |
COVID19 |
Relations of behavioral inhibition and activation system sensitivities with vaccination outcomes: Investigating the mediating role of vaccine hesitancy in older adults
2023-09-12 13:42:35 EST
Source
|
|
37. |
COVID19 |
Comparison of semen parameters in the same patients before and after diagnosis of COVID-19
2023-09-12 13:09:28 EST
Source
|
|
38. |
COVID19 |
SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of Immunodeficiency
2023-09-10 18:37:33 EST
Source
|
|
39. |
COVID19 |
What is the scientific rationale in not continuing to mass vaccinate?
2023-09-09 13:59:43 EST
Source
|
|
40. |
COVID19 |
Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant
2023-09-09 10:20:43 EST
Source
|
|
41. |
COVID19 |
Transmissibility, infectivity, and immune resistance of the SARS-CoV-2 BA.2.86 variant
2023-09-08 00:50:16 EST
Source
|
|
42. |
COVID19 |
First cases of SARS-CoV-2 BA.2.86 in Denmark, 2023
2023-09-07 15:10:00 EST
Source
|
|
43. |
COVID19 |
Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases
2023-09-07 10:48:06 EST
Source
|
|
44. |
COVID19 |
Forensic Analysis of the 38 Subject Deaths in the 6-Month Interim Report of the Pfizer/BioNTech BNT162b2 mRNA Vaccine Clinical Trial
2023-09-06 19:31:16 EST
Source
|
|
45. |
COVID19 |
Moderna Clinical Trial Data Confirm Its Updated Covid-19 Vaccine Generates Strong Immune Response in Humans Against BA.2.86
2023-09-06 18:28:56 EST
Source
|
|
46. |
COVID19 |
Long COVID Prevalence and the Impact of the Third SARS-CoV-2 Vaccine Dose: A Cross-Sectional Analysis from the Third Follow-Up of the Borriana Cohort, Valencia, Spain (2020-2022)
2023-09-05 23:30:46 EST
Source
|
|
47. |
COVID19 |
Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.2.86
2023-09-05 20:34:04 EST
Source
|
|
48. |
COVID19 |
Antigenicity and infectivity characterization of SARS-CoV-2 BA.2.86
2023-09-04 22:04:12 EST
Source
|
|
49. |
COVID19 |
Sensitivity of BA.2.86 to prevailing neutralising antibody responses
2023-09-04 21:32:18 EST
Source
|
|
50. |
COVID19 |
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)
2023-09-04 13:03:19 EST
Source
|
|
51. |
COVID19 |
XBB.1.5 Spike Protein COVID-19 Vaccine Induces Broadly Neutralizing and Cellular Immune Responses Against EG.5.1 and Emerging XBB Variants
2023-09-03 19:27:24 EST
Source
|
|
52. |
COVID19 |
Long COVID Complicated by Fatal Cytomegalovirus and Aspergillus Infection of the Lungs: An Autopsy Case Report
2023-09-03 10:18:20 EST
Source
|
|
53. |
COVID19 |
Characterization of an EG.5.1 clinical isolate in vitro and in vivo
2023-09-02 01:11:34 EST
Source
|
|
54. |
COVID19 |
Convergent evolution of SARS-CoV-2 XBB lineages on receptor-binding domain 455-456 enhances antibody evasion and ACE2 binding
2023-09-01 13:52:23 EST
Source
|
|
55. |
COVID19 |
Monthly Scientific Discussion Thread - September 2023
2023-09-01 08:02:02 EST
Source
|
|
56. |
COVID19 |
Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization
2023-09-01 00:26:25 EST
Source
|
|
57. |
COVID19 |
Detection of recombinant Spike protein in the blood of individuals vaccinated against SARS-CoV-2: Possible molecular mechanisms
2023-08-31 20:21:45 EST
Source
|
|
58. |
COVID19 |
Immune Evasion and Membrane Fusion of SARS-CoV-2 XBB Subvariants EG.5.1 and XBB.2.3
2023-08-31 10:08:41 EST
Source
|
|
59. |
COVID19 |
'Spikeopathy': COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
2023-08-31 08:55:51 EST
Source
|
|
60. |
COVID19 |
Long COVID in low-income and middle-income countries: the hidden public health crisis
2023-08-30 14:56:07 EST
Source
|
|
61. |
COVID19 |
BNT162b2 COVID-19 vaccination in children alters cytokine responses to heterologous pathogens and Toll-like receptor agonists
2023-08-29 19:05:02 EST
Source
|
|
62. |
COVID19 |
SARS-CoV-2 shedding and evolution in immunocompromised hosts during the Omicron period: a multicenter prospective analysis
2023-08-28 19:10:32 EST
Source
|
|
63. |
COVID19 |
‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
2023-08-28 06:35:23 EST
Source
|
|
64. |
COVID19 |
Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography
2023-08-28 06:00:40 EST
Source
|
|
65. |
COVID19 |
Measuring the quantity of harmful volatile organic compounds inhaled through masks
2023-08-27 21:54:06 EST
Source
|
|
66. |
COVID19 |
Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population
2023-08-27 17:57:21 EST
Source
|
|
67. |
COVID19 |
Safety and Immunogenicity of XBB.1.5-Containing mRNA Vaccines
2023-08-27 12:46:18 EST
Source
|
|
68. |
COVID19 |
Mucosal antibody responses to SARS-CoV-2 booster vaccination and breakthrough infection
2023-08-27 00:26:36 EST
Source
|
|
69. |
COVID19 |
Excess All-Cause Mortality in China After Ending the Zero COVID Policy
2023-08-26 11:00:21 EST
Source
|
|
70. |
COVID19 |
Meditation-induced bloodborne factors as an adjuvant treatment to COVID-19 disease
2023-08-26 02:54:44 EST
Source
|
|
71. |
COVID19 |
A friend of mine sent me this study. - Meditation-induced bloodborne factors as an adjuvant treatment to COVID-19 disease - I am skeptical about the sample size and the lack of diversification in the sample and survey group. Wanted to ask you guys what you think about it.
2023-08-25 15:52:00 EST
Source
|
|
72. |
COVID19 |
Report: COVID Pushed 68M Asians into Extreme Poverty
2023-08-25 12:39:25 EST
Source
|
|
73. |
COVID19 |
Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history
2023-08-24 23:43:20 EST
Source
|
|
74. |
COVID19 |
2m extra deaths recorded in China after zero Covid ended
2023-08-24 20:04:08 EST
Source
|
|
75. |
COVID19 |
Is the Vaccine-Only Strategy Sustainable?
2023-08-24 15:59:58 EST
Source
|
|
76. |
COVID19 |
Scientists traced the evolution of the coronavirus from the Wuhan variant to Omicron and found that most of the genomic mutations of SARS-CoV-2 occur due to processes in the guts and lungs. It is in these organs that the virus learns to evade the blocking microRNA molecules.
2023-08-24 05:00:36 EST
Source
|
|
77. |
COVID19 |
COVID-19: examining the effectiveness of non-pharmaceutical interventions
2023-08-23 21:25:36 EST
Source
|
|
78. |
COVID19 |
Acquired Immune Deficiency Syndrome correlation with SARS-CoV-2 N genotypes
2023-08-23 19:56:09 EST
Source
|
|
79. |
COVID19 |
about those masks....
2023-08-23 09:24:13 EST
Source
|
|
80. |
COVID19 |
Lessons From the COVID-19 Pandemic: Updating Our Approach to Masking in Health Care Facilities
2023-08-22 12:23:10 EST
Source
|
|
81. |
COVID19 |
Real-world effectiveness of molnupiravir and nirmatrelvir/ritonavir as treatments for COVID-19 in high-risk patients
2023-08-22 04:11:00 EST
Source
|
|
82. |
COVID19 |
Postacute sequelae of COVID-19 at 2 years
2023-08-21 13:07:28 EST
Source
|
|
83. |
COVID19 |
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months–5 Years — VISION Network, United States, July 2022–June 2023
2023-08-20 16:25:48 EST
Source
|
|
84. |
COVID19 |
Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin®)
2023-08-20 10:49:29 EST
Source
|
|
85. |
COVID19 |
Pathophysiology, diagnosis, and management of neuroinflammation in covid-19
2023-08-20 10:17:46 EST
Source
|
|
86. |
COVID19 |
SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial
2023-08-19 09:33:36 EST
Source
|
|
87. |
COVID19 |
Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin®) - npj Vaccines
2023-08-18 20:24:09 EST
Source
|
|
88. |
COVID19 |
Risk assessment for SARS-CoV-2 variant V-23AUG-01 (or BA.2.86)
2023-08-18 16:32:16 EST
Source
|
|
89. |
COVID19 |
SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in human airway and intestinal organoid models
2023-08-17 18:58:10 EST
Source
|
|
90. |
COVID19 |
Risk of autoimmune diseases following COVID-19 and the potential protective effect from vaccination: a population-based cohort study
2023-08-16 19:30:10 EST
Source
|
|
91. |
COVID19 |
COVID-19 Excess Deaths in Peru’s 25 States in 2020: Nationwide Trends, Confounding Factors, and Correlations With the Extent of Ivermectin Treatment by State
2023-08-16 15:06:04 EST
Source
|
|
92. |
COVID19 |
Exposure to lung-migrating helminth protects against murine SARS-CoV-2 infection through macrophage-dependent T cell activation
2023-08-16 13:04:56 EST
Source
|
|
93. |
COVID19 |
A possible cause of long covid fatigue and brain fog: excess WASF3 protein
2023-08-16 04:35:49 EST
Source
|
|
94. |
COVID19 |
Communication of COVID-19 Misinformation on Social Media by Physicians in the US
2023-08-15 13:12:49 EST
Source
|
|
95. |
COVID19 |
SARS-CoV-2 Neutralizing Antibodies Following a Second BA.5 Bivalent Booster
2023-08-14 21:29:05 EST
Source
|
|
96. |
COVID19 |
Yeni COVID 19 mutantı dünyaya yayılıyor
2023-08-14 09:20:56 EST
Source
|
|
© Copyright hackingthevirus.com
2022-2023 Release Version 1.11162020
Return to top ►
© Copyright hackingai.app 2022-2023 Release Version 1.01202023
Return to top ►